Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-593
Closed -$41.2K 1297
2023
Q3
$41.2K Buy
593
+12
+2% +$907 0.01% 497
2023
Q2
$43.5K Hold
581
0.01% 470
2023
Q1
$43.5K Hold
581
0.01% 468
2022
Q4
$43.5K Hold
581
0.01% 469
2022
Q3
$37K Buy
581
+10
+2% +$693 0.01% 566
2022
Q2
$40K Sell
571
-11
-2% -$817 0.01% 570
2022
Q1
$45K Buy
+582
New +$41.9K 0.01% 585
2019
Q2
Sell
-50
Closed -$2K 1141
2019
Q1
$2K Hold
50
﹤0.01% 1098
2018
Q4
$2K Buy
+50
New +$2.05K ﹤0.01% 1101

Other funds holding HOLX

FinTrust Capital Advisors's HOLX Position: Q4 2023 in Review

FinTrust Capital Advisors sold out of Hologic (HOLX) in Q4 2023, closing a stake of 593 shares — an estimated $41.2K sold.

FinTrust Capital Advisors first reported a position in HOLX in Q4 2018 and held it in 9 quarters. The position peaked at $45K in Q1 2022. 732 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • FinTrust Capital Advisors reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • FinTrust Capital Advisors sold 593 Hologic shares in Q4 2023, an estimated $41.2K.
  • FinTrust Capital Advisors first reported a position in Hologic in Q4 2018 and held it in 9 quarters.
  • FinTrust Capital Advisors's Hologic position peaked at $45K in Q1 2022.
  • 732 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on FinTrust Capital Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.